Hot Pot Stocks: Aurora Cannabis vs. GW Pharmaceuticals. Which Cannabis Stock To Buy?

POT STOCK TICKER

By Cristine Felt  Aurora Cannabis vs. GW Pharmaceuticals: Which Cannabis Stock To Buy? In this time and age when cannabis industry is simply blooming, it appears even an inexperienced rookie could try their hand at buying cannabis stocks and shares without the slightest fear of losing. Indeed, the global market is thought to be worth some Read the full article…

FSD Pharma Appoints Top GW Pharmaceuticals Executive As Chief Executive Officer

FSD Pharma

Management addition comes as FSD accelerates specialty cannabinoid pharmaceutical global expansion strategy CANADA:  FSD Pharma announced today the appointment of Rupert Haynes as Chief Executive Officer. Mr. Haynes is a highly accomplished healthcare executive with nearly three decades of global pharmaceutical experience having most recently held the position of Head of Global Marketing at GW Pharmaceuticals Read the full article…

Making Money From Marijuana

GW Pharmaceuticals is a speculative drug company that has a history of volatile trading. However, Cramer wouldn't be surprised if the more than 10 percent jump in the stock on Wednesday is just the start of this stock being... high.

NEW YORK: Making money from marijuana in the past used to require navigating the red tape of the law.  Jim Cramer has had his eye on one stock that is giving him quite a buzz. GW Pharmaceuticals is a speculative drug company that has a history of volatile trading. However, Cramer wouldn’t be surprised if the more Read the full article…

Marijuana’s Promise Of Profit Remains Elusive (For Now)

Those trials are all ongoing, so investors will need to rely on past trial data to make judgments on whether or not the market demand for GW Pharma's medicine will justify the company's $1.27 billion market cap.

NEW YORK: Excitement surrounding medical marijuana led to a significant run-up in GW Pharmaceuticals‘ share price earlier this year, but based on the company’s recently announced quarterly and fiscal full-year earnings results, the promise of marijuana profit remains far off in the distance. Planning for the future That’s because GW Pharma has only one marketed marijuana derived therapy, Read the full article…

Medical Pot: A Drugmaker Bets on Marijuana to Treat Diabetes, Epilepsy, and More

British pharma company makes big bet on cannabis

UNITED KINGDOM: Medicinal marijuana advocates contend that smoking pot helps relieve pain and alleviate nausea. British drug company GW Pharmaceuticals (GWP:LN) is betting that medicine made from cannabis can also treat maladies as diverse as diabetes, colitis, and epilepsy.